Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Cellulite may be linked to low adiponectin, isotretinoin with UVB can treat psoriasis effectively, permanent alopecia post-chemotherapy resembles a unique hair loss, deodorants may cause fragrance allergies, desmoplastic melanoma is becoming more common, and intensive UVB treatment can give long-term psoriasis remission.

Etanercept may not prevent alopecia areata from coming back.

Psoriasis on the scalp causes smaller oil glands and thinner hair but doesn't lead to hair loss.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Skin conditions like seborrheic dermatitis can make it harder to correctly diagnose hair loss because they can cause the oil glands in the skin to shrink.

Higher alarin levels might link hair loss and metabolic syndrome.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

A woman with severe hair loss was successfully treated with the drug adalimumab.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

The enzyme DHHC13 is essential for healthy hair and skin, and its deficiency leads to hair loss and skin problems.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

PRP injections did not significantly improve hair growth.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

Setipiprant did not significantly improve hair growth in men with hair loss.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Oral tofacitinib successfully treated total body hair loss in one patient.